Geode Capital Management, LLC Alx Oncology Holdings Inc Transaction History

Geode Capital Management, LLC

  • $1.39 Trillion
  • Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 315,421 shares of ALXO stock, worth $482,594. This represents 0.0% of its overall portfolio holdings.

Number of Shares
315,421
Previous 770,907 59.08%
Holding current value
$482,594
Previous $477,000 72.33%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025
SELL
$0.41 - $0.61 $186,749 - $277,846
-455,486 Reduced 59.08%
315,421 $132,000
Q1 2025

May 13, 2025
BUY
$0.62 - $1.86 $19,096 - $57,289
30,801 Added 4.16%
770,907 $477,000
Q4 2024

Feb 12, 2025
BUY
$1.21 - $1.87 $47,503 - $73,414
39,259 Added 5.6%
740,106 $1.24 Million
Q3 2024

Nov 12, 2024
BUY
$1.81 - $8.13 $798 - $3,585
441 Added 0.06%
700,847 $1.28 Million
Q2 2024

Aug 09, 2024
BUY
$5.84 - $17.56 $558,841 - $1.68 Million
95,692 Added 15.82%
700,406 $4.22 Million
Q1 2024

May 13, 2024
BUY
$10.95 - $16.79 $215,496 - $330,427
19,680 Added 3.36%
604,714 $6.74 Million
Q4 2023

Feb 13, 2024
BUY
$4.81 - $15.38 $682,861 - $2.18 Million
141,967 Added 32.04%
585,034 $8.71 Million
Q3 2023

Nov 13, 2023
SELL
$4.19 - $7.35 $5,157 - $9,047
-1,231 Reduced 0.28%
443,067 $2.13 Million
Q2 2023

Aug 11, 2023
BUY
$4.37 - $9.56 $101,619 - $222,308
23,254 Added 5.52%
444,298 $3.34 Million
Q1 2023

May 15, 2023
BUY
$4.52 - $11.71 $39,482 - $102,286
8,735 Added 2.12%
421,044 $1.9 Million
Q4 2022

Feb 13, 2023
BUY
$9.51 - $12.95 $180,575 - $245,894
18,988 Added 4.83%
412,309 $4.65 Million
Q3 2022

Nov 14, 2022
BUY
$8.23 - $15.14 $107,985 - $198,651
13,121 Added 3.45%
393,321 $3.76 Million
Q2 2022

Aug 12, 2022
BUY
$5.89 - $19.46 $352,569 - $1.16 Million
59,859 Added 18.69%
380,200 $3.08 Million
Q1 2022

May 13, 2022
SELL
$13.65 - $22.06 $266,243 - $430,280
-19,505 Reduced 5.74%
320,341 $5.41 Million
Q4 2021

Feb 11, 2022
SELL
$21.49 - $74.4 $440,544 - $1.53 Million
-20,500 Reduced 5.69%
339,846 $7.3 Million
Q3 2021

Nov 12, 2021
BUY
$52.51 - $80.91 $4.31 Million - $6.64 Million
82,069 Added 29.49%
360,346 $26.6 Million
Q2 2021

Aug 13, 2021
BUY
$52.2 - $75.23 $326,772 - $470,939
6,260 Added 2.3%
278,277 $15.2 Million
Q1 2021

May 12, 2021
BUY
$62.84 - $87.68 $5.73 Million - $7.99 Million
91,149 Added 50.4%
272,017 $20.1 Million
Q4 2020

Feb 12, 2021
BUY
$34.11 - $112.26 $895,012 - $2.95 Million
26,239 Added 16.97%
180,868 $15.6 Million
Q3 2020

Nov 13, 2020
BUY
$29.36 - $47.1 $4.54 Million - $7.28 Million
154,629 New
154,629 $5.84 Million

Others Institutions Holding ALXO

# of Institutions
67
Shares Held
31.6M
Call Options Held
53.8K
Put Options Held
11.7K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $62.3M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email